JIC Venture Growth Investments
〒100-0005 東京都千代田区丸の内1-4-1 丸の内永楽ビルディング 21階, Tokyo, Chiyoda-ku, 100-0005, Japan
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
SiccaNova Therapeutics | Sep 2026Participated | $8 MSeries A | |
Paytner | Sep 2026Led | $14 MSeries D | |
HERP | Aug 2026Participated | $12 MSeries C | |
Kyoto Fusioneering | Aug 2026Participated | $162 MSeries D | |
Letara | Aug 2026Led | $16 MSeries A | |
Rege Nephro | Jul 2026Participated | $11 MOther Equity | |
Beren Therapeutics | Jun 2026Participated | $245 MOther Equity | |
ATOM | May 2026Participated | $19 MSeed | |
Toregem BioPharma | May 2026Participated | $5 MSeries C | |
Henry | May 2026Participated | $19 MSeries C | |
Magic Shields | Apr 2026Led | $8 MSeries B | |
Restore Vision | Apr 2026Participated | $8 MSeries B | |
SiccaNova Therapeutics | Sep 2026Participated | $8 MSeries A | |
Paytner | Sep 2026Led | $14 MSeries D | |
HERP | Aug 2026Participated | $12 MSeries C | |
Kyoto Fusioneering | Aug 2026Participated | $162 MSeries D | |
Letara | Aug 2026Led | $16 MSeries A | |
Rege Nephro | Jul 2026Participated | $11 MOther Equity | |
Beren Therapeutics | Jun 2026Participated | $245 MOther Equity | |
ATOM | May 2026Participated | $19 MSeed | |
Toregem BioPharma | May 2026Participated | $5 MSeries C | |
Henry | May 2026Participated | $19 MSeries C | |
Magic Shields | Apr 2026Led | $8 MSeries B | |
Restore Vision | Apr 2026Participated | $8 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 5 | 8 |
| Series B | 4 | 9 |
| Series C+ | 2 | 13 |
| Other Equity | 1 | 4 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 3 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 3 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 2 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 1 |
| Jul '24 | 0 |
| Aug '24 | 2 |
| Sep '24 | 0 |
| Oct '24 | 2 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 3 |
| Sep '25 | 0 |
| Oct '25 | 2 |
| Nov '25 | 2 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 2 |
| Apr '26 | 3 |
| May '26 | 3 |
| Jun '26 | 1 |
| Jul '26 | 1 |
| Aug '26 | 3 |
| Sep '26 | 2 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 17 |
| Manufacturing | 12 |
| Space & Frontier Tech | 10 |
| Professional Services | 10 |
| Hardware & Robotics | 7 |
| AI & Machine Learning | 7 |
| Networks, Cloud & Communication | 6 |
| E-Commerce & Retail | 5 |
| Consumer & Lifestyle | 5 |
| Enterprise Software | 4 |
| Clean Energy & Sustainability | 4 |
| Fintech | 4 |
| Data, Analytics & IT | 3 |
| Transportation & Logistics | 3 |
| Marketing & Advertising | 3 |
| Media & Entertainment | 2 |
| Education & Workforce | 1 |
| Government & Defense | 1 |
| Real Estate & Construction | 1 |
| Crypto & Blockchain | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 5 |
| $5M-$10M | 7 |
| $10M-$25M | 20 |
| $25M-$50M | 6 |
| $50M-$100M | 3 |
| $100M-$250M | 6 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Japan | 37 |
| United States | 8 |
| Singapore | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Mitsubishi UFJ Capital | 13 |
| SMBC Venture Capital | 10 |
| Mizuho Capital | 9 |
| Jafco Ventures | 8 |
| Angel Bridge | 5 |
| ANRI | 5 |
| Daiwa Corporate Investment | 5 |
| DBJ Capital | 5 |
| SPARX Asset Management | 5 |
| Global Brain | 4 |
| Kyoto University Innovation Capital | 4 |
| Mizuho Bank | 4 |
| Aozora Corporate Investment | 3 |
| Astellas Venture Management | 3 |
| Chushin Venture Capital | 3 |
| Coral Capital | 3 |
| Development Bank of Japan | 3 |
| Globis Capital Partners | 3 |
| Nissay Capital | 3 |
| Osaka University Venture Capital | 3 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 12 | 26% |
| Participating | 35 | 74% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 4 | 33% |
| Co-led | 8 | 67% |
Team
Non Executive Director
Venture Capitalist in Life Science sector
CEO, President & Founder
Partner
プリンシパル
Principal